Arthrites juvéniles idiopathiques

Arthrites juvéniles idiopathiques

  
Al-Mayouf SM et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 2011;43:1186–8
Wakil SM et al.Mutation of LACC1 is associated with a Monogenic Form of Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol Hoboken NJ 2014;
De Benedetti F et al.Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2385–95.
De Benedetti F et al.Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: Results from the TENDER trial. Arthritis Rheumatol Hoboken NJ 2014;
Lire le résumé
Lovell DJ et al.Pediatric Rheumatology Collaborative Study Group (PRCSG); Paediatric Rheumatology International Trials Organization (PRINTO). Long-Term Safety, Efficacy, and Quality of Life with Intravenous Abatacept in Juvenile Idiopathic Arthritis: Up to 7 Years of Treatment. Arthritis Rheumatol. 2015 Jun 19
Lire le résumé
Put K et al.Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ. Rheumatology (Oxford). 2015 Aug;54(8):1507-17
Lire le résumé
Davies R et al.British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Arthritis Rheumatol. 2015 Sep
Lire le résumé
Lin C-H et al.Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study. Pediatr Rheumatol Online J. 10 mars 2016;14(1):15.Lire le résumé
Ravelli A et al.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol Hoboken NJ. mars 2016;68(3):566‑76.
Lire le résumé
Armbrust W et al.Fatigue in patients with juvenile idiopathic arthritis: A systematic review of the literature. Semin Arthritis Rheum. avr 2016;45(5):587‑95
Lire le résumé
Pacharapakornpong T et al. Comparisons of the outcomesbetween early and late tocilizumab treatment in systemic juvenile idiopathic arthritis. Rheumatol Int. 31 oct 2016;
Lire le résumé
Di Paola M et al.Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. Front Microbiol. 2016;7:1703.
Lire le résumé
McErlane F et al.Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study. Rheumatol Oxf Engl. juill 2016;55(7):1225‑34.
Lire le résumé
Shoop-Worrall SJW et al. How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition. Ann Rheum Dis. 2017 Apr 7;
Lire le résumé
Schulert GS et al. Biologic therapy modifies clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. Arthritis Care Res. 2017 May 12
Lire le résumé
Brunner HI et al. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial. Ann Rheum Dis. 2017 May 15;
Lire le résumé
Calvo-Río V et al. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients. Arthritis Rheumatol Hoboken NJ. 2017 Mar;69(3):668–75.
Lire le résumé
Alexeeva EI et al. Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children’s Health, Russia. Pediatr Rheumatol Online J. 2017 Jun 14;15(1):51
Lire le résumé
Ravelli A et al. Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. Lancet Lond Engl. 2017 Mar 4;389(10072):909–16.
Lire le résumé
Marasco E. Switched Memory B Cells Are Increased In Oligoarticular And Polyarticular Juvenile Idiopathic Arthritis And Their Change Over Time Is Related To Response To TNF Inhibitors. Arthritis Rheumatol. 2018 Jan 5. Lire le résumé
Lovell DJ et al. Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease. Arthritis Rheumatol. 2018 Mar 31Lire le résumé
Goirand M et al. Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre. Pediatr Rheumatol Online J. 2018 Apr 2Lire le résumé
Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, KonÉ-Paut I, et al. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2018 Mar;70(3):409–19. Lire le résumé
De Lucia O, Ravagnani V, Pregnolato F, Hila A, Pontikaki I, Gattinara M, et al. Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA). Annals of the Rheumatic Diseases. 2018 Feb 6;annrheumdis-2017-211696.Lire le résumé
Bayraktar D, Savci S, Altug-Gucenmez O, Manci E, Makay B, Ilcin N, et al. The effects of 8-week water-running program on exercise capacity in children with juvenile idiopathic arthritis: a controlled trial. Rheumatology International [Internet]. 2018 Nov 14 [cited 2018 Dec 19]Lire le résumé
Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, et al. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinu. Arthritis Rheumatol. mars 2019;71(3):451‐9Lire le résumé
Saccomanno B, Tibaldi J, Minoia F, Bagnasco F, Pistorio A, Guariento A, et al. Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis. J Rheumatol. avr 2019;46(4):416‐21Lire le résumé
Gohar F, McArdle A, Jones M, Callan N, Hernandez B, Kessel C, et al. Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis. Ann Rheum Dis. 20 avr 2019;annrheumdis-2019-215051Lire le résumé